Loss of Y chromosome in men enables cancer to grow, finds new study

by Cedars-Sinai Medical CenterCredit: Pixabay/CC0 Public DomainAs men age, some of their cells lose the very thing that makes them biological males—the Y chromosome—and this loss hampers the body

Updated on: January 30,2024

Loss of Y chromosome in men enables cancer to grow, finds new study

by Cedars-Sinai Medical CenterCredit: Pixabay/CC0 Public DomainAs men age, some of their cells lose the very thing that makes them biological males—the Y chromosome—and this loss hampers the body

Updated on:January 30,2024

BMI's relation to cancer therapy mortality risks not so straightforward, study finds

byOsaka Metropolitan UniversityFor non-small cell lung cancer treatment, immunotherapy seems to pose less risk for persons under a certain BMI, while conventional chemotherapy appears optimal fo

Updated on: September 27,2024

BMI's relation to cancer therapy mortality risks not so straightforward, study finds

byOsaka Metropolitan UniversityFor non-small cell lung cancer treatment, immunotherapy seems to pose less risk for persons under a certain BMI, while conventional chemotherapy appears optimal fo

Updated on:September 27,2024

High fail rate for melanoma self-checks increasing cancer risk, new study finds

bySouthern Cross UniversityCredit: ROCKETMANN TEAM from PexelsAustralians are unable to recognize malignant melanomas on their own skin, calling into question the effectiveness of national self-

Updated on: July 05,2024

High fail rate for melanoma self-checks increasing cancer risk, new study finds

bySouthern Cross UniversityCredit: ROCKETMANN TEAM from PexelsAustralians are unable to recognize malignant melanomas on their own skin, calling into question the effectiveness of national self-

Updated on:July 05,2024

Immunotherapy was meant to defeat cancer—what happened to the great promise?

by Jonathan Fisher,The ConversationCredit: Ivan Samkov from PexelsIn 1893, theAmerican Journal of the Medical Sciencesreported on 10 patients whose large and hitherto incurable cance

Updated on: November 10,2024

Immunotherapy was meant to defeat cancer—what happened to the great promise?

by Jonathan Fisher,The ConversationCredit: Ivan Samkov from PexelsIn 1893, theAmerican Journal of the Medical Sciencesreported on 10 patients whose large and hitherto incurable cance

Updated on:November 10,2024

Novel anti-cancer nanomedicine for efficient chemotherapy

by University of HelsinkiThe new exosome-based nanomedicines enhanced tumor accumulation, extravasation from blood vessels and penetration into deep tumor parenchyma after intravenous administrat

Updated on: May 09,2024

Novel anti-cancer nanomedicine for efficient chemotherapy

by University of HelsinkiThe new exosome-based nanomedicines enhanced tumor accumulation, extravasation from blood vessels and penetration into deep tumor parenchyma after intravenous administrat

Updated on:May 09,2024

Researchers discover method to 'turn off' mutated melanoma

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Melanoma is the deadliest f

Updated on: June 22,2024

Researchers discover method to 'turn off' mutated melanoma

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Melanoma is the deadliest f

Updated on:June 22,2024

Researchers develop modular approach to engineering immune cells

by Bara Badwan,Yale UniversityCredit: stock.adobe.comYale researchers have developed a new way to efficiently engineer immune cells, an advance which enhances the ability to fend off cancer and

Updated on: June 08,2024

Researchers develop modular approach to engineering immune cells

by Bara Badwan,Yale UniversityCredit: stock.adobe.comYale researchers have developed a new way to efficiently engineer immune cells, an advance which enhances the ability to fend off cancer and

Updated on:June 08,2024

A machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

by Institute for Research in Biomedicine (IRB Barcelona)Credit: CC0 Public DomainScientists at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with the Centre for Geno

Updated on: May 20,2024

A machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

by Institute for Research in Biomedicine (IRB Barcelona)Credit: CC0 Public DomainScientists at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with the Centre for Geno

Updated on:May 20,2024

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on: March 30,2024

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on:March 30,2024

Researchers suggest new way to target third most common oncogene, TERT

by Garth Sundem,CU Anschutz Medical CampusChromosome, showing telomeres in pink. Credit: CUHealthy cells have a built-in self-destruct mechanism: Strands of DNA called "telomeres" act

Updated on: March 01,2024

Researchers suggest new way to target third most common oncogene, TERT

by Garth Sundem,CU Anschutz Medical CampusChromosome, showing telomeres in pink. Credit: CUHealthy cells have a built-in self-destruct mechanism: Strands of DNA called "telomeres" act

Updated on:March 01,2024

Team finds key to common cancer pathway

by Terry Devitt,University of Wisconsin-MadisonThe molecular pathway for the protein p53, commonly associated with many cancers, is illuminated in this micrograph. The p53 - PIP2 complex is show

Updated on: May 27,2024

Team finds key to common cancer pathway

by Terry Devitt,University of Wisconsin-MadisonThe molecular pathway for the protein p53, commonly associated with many cancers, is illuminated in this micrograph. The p53 - PIP2 complex is show

Updated on:May 27,2024

Immune response against skin-dwelling viruses prevents cancer

by Massachusetts General HospitalEarly skin cancer that is colonized with a commensal papillomavirus looks like a wart to the immune system and is effectively eliminated. Keratin 6+ hyperplastic

Updated on: April 14,2024

Immune response against skin-dwelling viruses prevents cancer

by Massachusetts General HospitalEarly skin cancer that is colonized with a commensal papillomavirus looks like a wart to the immune system and is effectively eliminated. Keratin 6+ hyperplastic

Updated on:April 14,2024